Skip to main content
. Author manuscript; available in PMC: 2020 Aug 11.
Published before final editing as: Dev Psychopathol. 2019 Feb 11:1–9. doi: 10.1017/S0954579418001682

Table 2.

ANOVA Results for Studies 1–3

Study 1 Study 2 Study 3
PLE: n = 262 CHR: n = 29 SZ: n = 61
NPLE: n= 1226 CN: n = 29 CN: n = 67
Group F = 0.93, d = 0.06 F = 2.16, d=0.41 F = 1.39, d = 0.20
Strategy F = 0.44, d = 0.03 F = 38.60***, d= 1.67 F = 29.58***, d = 0.97
Group × Strategy F= 38.22***, d= 0.47 F= 12.34**, d= 1.26 F= 6.49*, d= 0.62
Post Hoc Oneway ANOVAs
Reappraisal F = 6.65*, d = 0.13 F = 12.73**, d = 0.95 F = 7.84**, d= 0.50
Suppression F= 17.62***, d= 0.22 F = 1.28, d= 0.30 F= 1.09, d = 0.19

Note.

***

p < 0.001;

**

p < 0.01;

*

p < 0.05.

PLE = individuals with psychotic-like experiences; NPLE = individuals without psychotic-like experiences; CHR = individuals at clinical high-risk; CN = controls; SZ = schizophrenia outpatients.